Lignanamides from the roots of Limonium gmelinii (Willd.) Kuntze and their anti-diabetic, cytotoxic and anti-inflammatory activities

Amanguli Tuohongerbieke,Jun Li,Gulnar Sabir,Xuelei Xin,Miao Hu,Xiaomei Duan,Liu Liu,Dan Tang,Jun Zhu,Haji Akber Aisa
DOI: https://doi.org/10.1016/j.phytochem.2020.112648
IF: 3.8
2021-04-01
Phytochemistry
Abstract:<p>Nine undescribed lignanamides, limoniumins A−I, together with ten known lignanamides and two known phenolics were isolated from ethyl acetate extract of the roots of <em>Limonium gmelinii</em> (Plumbaginaceae). Their structures were determined by spectroscopic analysis including 1D and 2D NMR and HRESIMS experiments. Limoniumin A is the first hybrid lignanamide of phenylpropanoid and coumarin. All tested lignanamides showed significant inhibitory activity against <em>α</em>-glucosidase stronger than positive control and remarkable inhibitory effect to PTP1B with IC<sub>50</sub> values less than 10 <em>μ</em>M. In addition, some lignanamides exhibited moderate cytotoxic activity against HeLa and MCF-7 cells and anti-inflammatory activity against COX-2 in a dose-dependent way.</p>
biochemistry & molecular biology,plant sciences
What problem does this paper attempt to address?